California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on June 29, 2026

Jun. 29, 2026

Del Rae Behavioral Health Addresses Growing College Student Mental Health Crisis with Outpatient Program in San Diego

Indeterminate EIN Presswire

Jun. 29, 2026

Bonmente Outlines Evidence-Based Techniques for Building Frustration Tolerance

Indeterminate EIN Presswire

Jun. 29, 2026

Amend Treatment Ranks Among the Top 5-15% of Residential Mental Health Centers Nationwide for 2025 Measurable Outcomes

Indeterminate EIN Presswire

Jun. 29, 2026

Ascendo AI Reflects on Key HTM and Clinical Engineering Conversations from AAMI eXchange 2026

Indeterminate EIN Presswire

Jun. 29, 2026

CodaPet partners with Dr. Germaine Germundson to expand its compassionate in-home pet euthanasia services in Carlsbad.

Indeterminate EIN Presswire

Jun. 29, 2026

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2

Indeterminate GlobeNewswire

Jun. 29, 2026

Guangdong Baoshan Trading: Multi-Grade PVC Vinyl Supply Chain and Quality Control for Global Procurement

Indeterminate EIN Presswire

Jun. 29, 2026

Twentyeight Health partners with Clue to expand access to affordable birth control nationwide

Indeterminate GlobeNewswire

Jun. 29, 2026

PetVivo Reports Financial and Operational Results for Fiscal 2026

Indeterminate GlobeNewswire

Jun. 29, 2026

Zoumalan, MD FACS Inc. Announces Its Natural Looking Blepharoplasty® Approach as Demand Grows for Natural Eyelid Surgery Results

Indeterminate GlobeNewswire

Jun. 29, 2026

Tilray Brands Strengthens Global Medical Cannabis Platform and Canadian Patient Access Through HelloMD Acquisition

Indeterminate GlobeNewswire

Jun. 29, 2026

FISHER HOUSE FOUNDATION RECEIVES “FOUR STARS” FOR 22nd YEAR FROM CHARITY NAVIGATOR, A+ FROM CHARITY WATCH

Indeterminate GlobeNewswire

Jun. 29, 2026

Publication relating to transparency notifications

Indeterminate GlobeNewswire

Jun. 29, 2026

Publication relative à des notifications de transparence

Indeterminate GlobeNewswire

Jun. 29, 2026

Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies

Indeterminate GlobeNewswire

Jun. 29, 2026

Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request

Indeterminate GlobeNewswire

Jun. 29, 2026

Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

Indeterminate GlobeNewswire

Jun. 29, 2026

Dragon Pharma Store Announces Expansion of Research Product Catalog with Addition of KLOW 80mg

Indeterminate GlobeNewswire

Jun. 29, 2026

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

Indeterminate GlobeNewswire

Jun. 29, 2026

Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité

Indeterminate GlobeNewswire